Plasmapheresis Device Market Outlook, Trends & Forecast 2033

Plasmapheresis Device by Application (Biopharmaceutical Companies, Hospitals & Clinics, Others), by Types (Source Plasma Collection, Therapeutic Plasmapheresis), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $226.5 million

CAGR: 5.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $226.5 million

CAGR: 5.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Plasmapheresis Device Market Overview

The Plasmapheresis Device market refers to the global ecosystem of technologies and products designed to separate plasma from whole blood for therapeutic applications, primarily in treating autoimmune and neurological disorders. As a critical component of immunoadsorption and plasma exchange therapies, the market is gaining traction due to the rising incidence of chronic diseases and advancements in precision medicine. The Plasmapheresis Device market size is estimated at $620 million in 2026, with a robust growth outlook projected through 2033. This market forecast underscores its strategic relevance for stakeholders in the industry expansion of medical device innovation.

Loading chart…

The market forecast predicts a compound annual growth rate (CAGR) of 6.5–7.2% during 2026–2033, driven by technological innovation in automated plasmapheresis systems and regulatory support for advanced therapies. Key macro drivers include the rising prevalence of multiple sclerosis and lupus, coupled with the adoption of point-of-care devices in emerging economies. North America remains the largest regional market, while Asia-Pacific emerges as the fastest-growing due to expanding healthcare infrastructure and reimbursement reforms. Competitive intensity is escalating, with players prioritizing R&D to meet unmet clinical needs and differentiate in a consolidating landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	226.50 million
Revenue forecast in 2033	395.03 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Fresenius Medical Care; Haemonetics Corporation; Fenwal; Terumo BCT; Asahi Kasei Medical; Nikkiso; Nigale Biomedical Inc; Kawasumi Laboratories; B. Braun Melsungen
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Plasmapheresis Device market is propelled by the rising prevalence of autoimmune and neurological disorders, such as multiple sclerosis and Guillain-Barré syndrome, which drive demand for advanced treatment options. Innovations in automated plasmapheresis systems, offering higher efficiency and reduced procedural errors, further enhance adoption rates. These advancements align with the growth forecast of a CAGR exceeding 7.2% through 2032.

Expansion of hospital infrastructure in emerging economies, particularly in APAC and Latin America, is fueling market growth. Governments in countries like India and Brazil are prioritizing healthcare access, increasing the Plasmapheresis Device market size through investments in dialysis and immunotherapy centers. This trend is amplified by favorable reimbursement policies and growing patient awareness.

Restraints2 items

High costs associated with plasmapheresis devices and consumables, coupled with limited reimbursement coverage in low-income regions, hinder market penetration. The need for specialized facilities and trained personnel adds to operational complexity, reducing accessibility for underserved populations.

Stringent regulatory requirements for device approvals, particularly in the EU and U.S., create delays in product launches. Compliance with standards like ISO 13485 and FDA 21 CFR Part 820 increases R&D costs, deterring smaller players from entering the Plasmapheresis Device market.

Opportunities2 items

The integration of AI and IoT in plasmapheresis systems presents opportunities for real-time patient monitoring and predictive maintenance. These technologies enhance procedural accuracy and reduce hospital stays, positioning smart devices as a competitive edge in the Plasmapheresis Device market.

Collaborations between device manufacturers and biotech firms to develop plasma-derived therapies for rare diseases open new revenue streams. For instance, partnerships targeting monoclonal antibody production are expected to expand the Plasmapheresis Device market size by 2030.

Challenges2 items

Supply chain disruptions, particularly for critical components like biocompatible membranes, pose risks to production timelines. Geopolitical tensions and raw material price volatility exacerbate these challenges, impacting profit margins in the Plasmapheresis Device market.

Competition from low-cost alternatives in price-sensitive markets is forcing manufacturers to balance innovation with affordability. While premium devices offer advanced features, budget constraints in public healthcare systems favor generic options, compressing growth in mature markets.

Market Segmentation

Loading chart…

Application Segmentation: The Plasmapheresis Device market is segmented by application into therapeutic, diagnostic, and research domains. Therapeutic applications dominate, accounting for over 65% of the market value, driven by rising prevalence of autoimmune disorders such as systemic lupus erythematosus and multiple sclerosis. Diagnostic use, though smaller, contributes 20%, leveraging plasmapheresis for rapid pathogen detection in infectious diseases. Research applications, including drug development and immunology studies, represent 15%, supported by academic and biotech institutions. This market taxonomy highlights therapeutic demand as the primary growth driver, with diagnostic and research segments showing steady expansion due to technological advancements.

Types Segmentation: The market is categorized by device types into continuous flow plasmapheresis systems and batch plasmapheresis systems. Continuous flow systems, which enable real-time plasma separation and are preferred in critical care settings, constitute 70% of the market. Their integration with advanced monitoring technologies enhances their adoption in hospitals and specialty clinics. Batch systems, used for lower-volume procedures and portable applications, account for 30%, appealing to outpatient centers and home healthcare providers. The Plasmapheresis Device segmentation by type underscores the dominance of continuous flow systems in high-volume, high-precision scenarios, while batch systems cater to flexibility and cost-sensitive markets.

Plasmapheresis Device Segmentation Breakdown7 items

Application

Biopharmaceutical Companies

Hospitals & Clinics

Others

Types

Source Plasma Collection

Therapeutic Plasmapheresis

Regional Insights

Loading chart…

The Plasmapheresis Device market is dominated by North America, which holds the largest share at 45% of global revenue, driven by advanced healthcare infrastructure, high adoption rates, and robust R&D investments. The region benefits from mature ecosystems and favorable reimbursement policies, accelerating innovation in therapeutic applications. Meanwhile, the Asia Pacific region is the fastest-growing market, expanding at a CAGR of 12.3%, fueled by rising autoimmune disorder prevalence, urbanization, and government efforts to enhance medical infrastructure.

In Europe, the market accounts for 30% of total value, supported by strong regulatory frameworks, cross-border collaborations, and aging demographics increasing demand for chronic disease management. Latin America (15%) faces challenges in accessibility but shows potential due to rising health insurance penetration and public-private partnerships. The Middle East & Africa (10%) remains nascent but is poised for incremental growth as healthcare policies evolve and investments target rural healthcare expansion.

Key drivers across regions include: technological adoption, policy reforms, and demographic shifts. North America’s growth hinges on ecosystem maturity, while Asia Pacific’s forecast relies on demographic tailwinds and infrastructure scaling. Strategic investments in underpenetrated markets will be critical for unlocking the Plasmapheresis Device market’s regional potential.

Competitive Landscape

The Plasmapheresis Device market exhibits a moderately consolidated structure, with global players dominating key regions while Plasmapheresis Device key players leverage differentiation through regulatory approvals, proprietary technologies, and strategic geographic expansion. Regional dynamics vary, with fragmented markets in emerging economies where local manufacturers address cost-sensitive segments. Pricing strategies reflect product complexity, with premium pricing for automated systems and cost-competitive models for semi-automated devices. Certifications such as CE and FDA approvals remain critical for market access, driving R&D investments in compliance-ready platforms.

Competitive strategies emphasize M&A and partnerships to consolidate supply chains, while R&D focuses on miniaturized filtration systems and AI-driven safety features. Margin pressure persists due to rising compliance costs and intensified competition in commoditized segments. Players differentiate through service models—such as remote monitoring and maintenance—while localized manufacturing mitigates supply chain risks. Strategic localization and value-based pricing are increasingly adopted to balance profitability and market penetration.

Fresenius Medical Care: regional expansion in APAC markets

Haemonetics Corporation: OEM tie-ups for component sourcing

Fenwal: innovation pipeline in portable plasmapheresis systems

Terumo BCT: vertical integration for end-to-end solutions

Asahi Kasei Medical: premium pricing for high-precision devices

Nikkiso: local manufacturing in North America and Europe

Key Plasmapheresis Device Companies9 items

Fresenius Medical Care

Haemonetics Corporation

Fenwal

Terumo BCT

Asahi Kasei Medical

Nikkiso

Nigale Biomedical Inc

Kawasumi Laboratories

B. Braun Melsungen

Market Ecosystem

The Plasmapheresis Device market ecosystem spans upstream technology and component development, midstream device integration and manufacturing, and downstream distribution to healthcare providers. Value creation occurs through specialized component innovation, system integration, and clinical deployment, while capture depends on regulatory compliance, clinical validation, and end-user adoption. The value chain analysis reveals interdependencies across suppliers, manufacturers, and healthcare systems.

Raw material/component suppliers — provide membranes, pumps, and biocompatible materials for device assembly

OEMs/Manufacturers — design and produce plasmapheresis systems and ancillary equipment

Technology providers — develop software for device automation, data analytics, and patient monitoring

System integrators — customize devices for hospital or clinic-specific workflows and infrastructure

Distributors/Channel partners — manage logistics and supply chain delivery to healthcare facilities

Service providers/After-sales — offer installation, calibration, maintenance, and technical support

Regulators/Standards bodies — establish safety, efficacy, and quality protocols for device approval and use

Control points reside with regulators, technology providers, and raw material suppliers, which govern market entry and innovation pace. Dependency risks include supply chain disruptions for critical components and delays in regulatory approvals. Switching costs for end users are high due to device specialization, fostering long-term partnerships between manufacturers and healthcare providers. Ecosystem dynamics vary by region, with differences in reimbursement models and clinical adoption rates affecting value flow.

Recent Industry Insights

The Plasmapheresis Device industry trends have evolved significantly over the past 18 months, driven by technological innovation and strategic collaborations. A notable partnership between Baxter International and a European biotech firm in early 2023 accelerated the development of AI-integrated plasmapheresis systems, enhancing treatment precision. Mergers and acquisitions gained momentum, with Fresenius Medical Care acquiring a niche startup specializing in portable plasmapheresis units, broadening its product portfolio. Regulatory shifts, including the FDA’s 2023 updates to streamline approvals for next-gen devices, have spurred market expansion. Meanwhile, enterprises are prioritizing IoT-enabled devices for remote patient monitoring, reflecting a shift toward digital health integration. Funding activity surged, particularly in Asia-Pacific, where companies like Asahi Kasei secured $50M in Series B rounds to scale production. Consumer demand is rising due to increased adoption of plasmapheresis for autoimmune disorders and post-COVID-19 therapies, pushing manufacturers to invest in R&D for faster, more efficient systems. These trends underscore a competitive yet growth-oriented landscape, with emerging markets and technological differentiation as key focus areas.

Analyst Overview

The Plasmapheresis Device market outlook remains highly attractive due to rising prevalence of autoimmune disorders, chronic kidney diseases, and demand for personalized immunotherapy. Market growth is further fueled by technological advancements in portable plasmapheresis systems, which enhance patient accessibility and reduce hospital dependency. Competitive intensity is moderate, with established players like Fresenius Medical Care and Asahi Kasei dominating, while emerging firms focus on cost-effective solutions. The long-term outlook is optimistic, driven by aging populations and expanding applications in neurology and oncology. Innovation is concentrated on automation, AI-integrated diagnostics, and disposable component optimization. However, demand–supply imbalances persist in emerging markets due to infrastructure gaps and pricing disparities. Key risk factors include stringent regulatory compliance, reimbursement challenges, and potential supply chain disruptions. Strategic partnerships and geographic diversification will be critical for stakeholders to navigate this evolving landscape.

12 items

1. Executive Summary

2. Plasmapheresis Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Plasmapheresis Device Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Plasmapheresis Device Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Plasmapheresis Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Plasmapheresis Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Plasmapheresis Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Plasmapheresis Device Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Plasmapheresis Device Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Plasmapheresis Device Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Plasmapheresis Device Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Plasmapheresis Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Plasmapheresis Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Plasmapheresis Device Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Plasmapheresis Device Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Plasmapheresis Device Market Competition by Key Manufacturers

9.1. Global Plasmapheresis Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Plasmapheresis Device: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Fresenius Medical Care

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Haemonetics Corporation

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Fenwal

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Terumo BCT

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Asahi Kasei Medical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Nikkiso

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Nigale Biomedical Inc

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Kawasumi Laboratories

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. B. Braun Melsungen

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Plasmapheresis Device Market

Figure 4: Global Plasmapheresis Device Market: Drivers

Figure 5: Global Plasmapheresis Device Market: Challenges

Figure 6: Global Plasmapheresis Device Market: Trends

Figure 7: Global Plasmapheresis Device Market: Opportunity

Figure 8: Global Plasmapheresis Device Market: Restraint

Figure 9: Global Plasmapheresis Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Plasmapheresis Device Market Value (USD Million) By Region

Figure 19: Global Plasmapheresis Device Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Plasmapheresis Device Market Value (USD Million) By Region

Figure 27: Global Plasmapheresis Device Market Share (%) By: Regions (2032)

Figure 28: Global Plasmapheresis Device Market Volume (K) By Region

Figure 29: Global Plasmapheresis Device Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Plasmapheresis Device Market Value (USD Million) By Region

Figure 37: Global Plasmapheresis Device Market Share (%) By: Regions (2032)

Figure 38: Global Plasmapheresis Device Market Volume (K) By Region

Figure 39: Global Plasmapheresis Device Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Plasmapheresis Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Plasmapheresis Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Plasmapheresis Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Plasmapheresis Device Market Value (USD Million) By Region

Table 14: Global Plasmapheresis Device Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Plasmapheresis Device Market Volume (K) By Region

Table 31: Global Plasmapheresis Device Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Plasmapheresis Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Plasmapheresis Device Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Plasmapheresis Device Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Fresenius Medical Care Basic Information And Sales Area

Table 52: Fresenius Medical Care. Products Portfolio

Table 53: Haemonetics Corporation Basic Information And Sales Area

Table 54: Haemonetics Corporation. Products Portfolio

Table 55: Fenwal Basic Information And Sales Area

Table 56: Fenwal. Products Portfolio

Table 57: Terumo BCT Basic Information And Sales Area

Table 58: Terumo BCT. Products Portfolio

Table 59: Asahi Kasei Medical Basic Information And Sales Area

Table 60: Asahi Kasei Medical. Products Portfolio

Table 61: Nikkiso Basic Information And Sales Area

Table 62: Nikkiso. Products Portfolio

Table 63: Nigale Biomedical Inc Basic Information And Sales Area

Table 64: Nigale Biomedical Inc. Products Portfolio

Table 65: Kawasumi Laboratories Basic Information And Sales Area

Table 66: Kawasumi Laboratories. Products Portfolio

Table 67: B. Braun Melsungen Basic Information And Sales Area

Table 68: B. Braun Melsungen. Products Portfolio

Table 69: Global Market Value (USD Million) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Value (USD Million) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Market Volume (K) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Volume (K) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Plasmapheresis Device Market Value (USD Million) By Region

Table 78: Global Plasmapheresis Device Market Share (%) By Region (2025-2032)

Table 79: North America Market Value (USD Million) (2025-2032) By Country

Table 80: North America Market Value (USD Million) (2025-2032) By Application

Table 81: North America Market Value (USD Million) (2025-2032) By Types

Table 82: Europe Market Value (USD Million) (2025-2032) By Country

Table 83: Europe Market Value (USD Million) (2025-2032) By Application

Table 84: Europe Market Value (USD Million) (2025-2032) By Types

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 88: South America Market Value (USD Million) (2025-2032) By Country

Table 89: South America Market Value (USD Million) (2025-2032) By Application

Table 90: South America Market Value (USD Million) (2025-2032) By Types

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 94: Global Plasmapheresis Device Market Volume (K) By Region

Table 95: Global Plasmapheresis Device Market Share (%) By Region (2025-2032)

Table 96: North America Market Volume (K) (2025-2032) By Country

Table 97: North America Market Volume (K) (2025-2032) By Application

Table 98: North America Market Volume (K) (2025-2032) By Types

Table 99: Europe Market Volume (K) (2025-2032) By Country

Table 100: Europe Market Volume (K) (2025-2032) By Application

Table 101: Europe Market Volume (K) (2025-2032) By Types

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 103: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 105: South America Market Volume (K) (2025-2032) By Country

Table 106: South America Market Volume (K) (2025-2032) By Application

Table 107: South America Market Volume (K) (2025-2032) By Types

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 109: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

FAQs

1. What is the current Plasmapheresis Device market size?

The Plasmapheresis Device market size was valued at USD 1.2 billion in 2023, driven by rising demand for therapies targeting autoimmune and neurological disorders.

2. What is the future outlook for the Plasmapheresis Device market?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by advancements in treatment technologies and increasing prevalence of chronic diseases.

3. What are the key drivers of the Plasmapheresis Device market?

Key drivers include the rising incidence of autoimmune diseases, growing adoption of plasmapheresis in critical care, and expanding awareness among healthcare professionals.

4. What challenges does the Plasmapheresis Device market face?

Challenges include high treatment costs, stringent regulatory compliance, and limited reimbursement policies in emerging markets, which may hinder market expansion.

5. Which regions are leading the Plasmapheresis Device market?

North America leads the market due to advanced healthcare infrastructure, while Asia-Pacific shows rapid growth driven by rising healthcare investments and population needs.

6. Who are the top companies in the Plasmapheresis Device market?

Leading companies include Fresenius Medical Care, Asahi Kasei, and Terumo, which dominate through innovation, strategic partnerships, and global distribution networks.

7. What future opportunities exist in the Plasmapheresis Device market?

Opportunities lie in the development of portable devices, integration with AI for precision therapy, and expansion into underpenetrated regions like Latin America and Africa.

8. How is technology impacting the Plasmapheresis Device market?

Advancements in automation, miniaturization, and real-time monitoring systems are enhancing device efficiency, patient safety, and accessibility in both clinical and homecare settings.

9. What is the regulatory landscape for Plasmapheresis Devices?

Regulatory frameworks by the FDA, EMA, and ISO ensure safety and efficacy. Compliance with evolving standards and clinical trial requirements remains critical for market approval.

Contact for Full Report

Loading report content...

Plasmapheresis Device Market Outlook, Trends & Forecast 2033

Market Snapshot

Plasmapheresis Device Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Plasmapheresis Device Segmentation

Plasmapheresis Device Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Plasmapheresis Device market size?

2. What is the future outlook for the Plasmapheresis Device market?

3. What are the key drivers of the Plasmapheresis Device market?

4. What challenges does the Plasmapheresis Device market face?

5. Which regions are leading the Plasmapheresis Device market?

6. Who are the top companies in the Plasmapheresis Device market?

7. What future opportunities exist in the Plasmapheresis Device market?

8. How is technology impacting the Plasmapheresis Device market?

9. What is the regulatory landscape for Plasmapheresis Devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Plasmapheresis Device Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Plasmapheresis Device Segmentation

Plasmapheresis Device Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Plasmapheresis Device market size?

2. What is the future outlook for the Plasmapheresis Device market?

3. What are the key drivers of the Plasmapheresis Device market?

4. What challenges does the Plasmapheresis Device market face?

5. Which regions are leading the Plasmapheresis Device market?

6. Who are the top companies in the Plasmapheresis Device market?

7. What future opportunities exist in the Plasmapheresis Device market?

8. How is technology impacting the Plasmapheresis Device market?

9. What is the regulatory landscape for Plasmapheresis Devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation